EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR activation and interference as investigative tools in the cardiovascular system

Melissa S Carroll, Mauro Giacca

The International Journal of Biochemistry & Cell Biology · 2023-02 · 155 · 106348

DOI: 10.1016/j.biocel.2022.106348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2023-02. Verfasst von Melissa S Carroll und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London, London …. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Cardiovascular System. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR activation and interference (CRISPRa/i) technology offers the unprecedented possibility of achieving regulated gene expression both in vitro and in vivo. The DNA pairing specificity of a nuclease dead Cas9 (dCas9) is exploited to precisely target a transcriptional activator or repressor in proximity to a gene promoter. This permits both the study of phenotypes arising from gene modulation for investigative purposes, and the development of potential therapeutics. As with virtually all other organ systems, the cardiovascular system can deeply benefit from a broader utilisation of CRISPRa/i. However, application of this technology is still in its infancy. Significant areas for improvement include the identification of novel and more effective transcriptional regulators that can be docked to dCas9, and the development of more efficient methods for their delivery and expression in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsCardiovascular SystemTranscriptional ActivationTranscription FactorsRNA, Guide, CRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPRCardiovascularDCas9Transcriptional regulation

Substanzen

Transcription FactorsRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London, London UK.
  • School of Cardiovascular and Metabolic Medicine & Sciences and British Heart Foundation Centre of Research Excellence, King's College London, London UK. Electronic address: mauro.giacca@kcl.ac.uk.

Förderung

  • British Heart Foundation

Zitieren

APA

Carroll, M. S., & Giacca, M. (2023). CRISPR activation and interference as investigative tools in the cardiovascular system. The International Journal of Biochemistry & Cell Biology, 155, 106348. https://doi.org/10.1016/j.biocel.2022.106348

Vancouver

Carroll MS, Giacca M. CRISPR activation and interference as investigative tools in the cardiovascular system. The International Journal of Biochemistry & Cell Biology. 2023;155:106348. doi:10.1016/j.biocel.2022.106348

BibTeX
@article{Carroll2023,
  author = {Carroll, Melissa S and Giacca, Mauro},
  title = {CRISPR activation and interference as investigative tools in the cardiovascular system},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2023},
  volume = {155},
  pages = {106348},
  doi = {10.1016/j.biocel.2022.106348}
}
Kostenlos starten →